Search

Your search keyword '"Sunnie S. Kim"' showing total 5 results
Start Over Author "Sunnie S. Kim" Journal annals of oncology
5 results on '"Sunnie S. Kim"'

2. 1437TiP Phase Ib/II, open label, dose escalation and expansion trial of tucatinib in combination with trastuzumab and oxaliplatin-based chemotherapy in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in Progress)

Author

Suneel Deepak Kamath, T. S. Bekaii-Saab, Haeseong Park, James M. Ford, C. Lux, Sunnie S. Kim, Michael J. Pishvaian, John H. Strickler, D. Zhen, J.G. Mayor, and Q. Tan

Subjects
Oncology, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Hematology, Oxaliplatin, Trastuzumab, Internal medicine, Dose escalation, medicine, In patient, Open label, business, medicine.drug
Published
2021
Full Text
View/download PDF

3. 195TiP GLOW: Phase III study of first-line zolbetuximab + CAPOX versus placebo + CAPOX in Claudin18.2⁺/HER2⁻ advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)

Author

David H. Ilson, K. Shitara, Ahsan M. Arozullah, Daniel Virgil Thomas Catenacci, Y.-J. Bang, Jaffer A. Ajani, Jung Wook Park, Peter C. Enzinger, Sunnie S. Kim, Florian Lordick, S-E. Al-Batran, R. Xu, Manish A. Shah, and E. Van Cutsem

Subjects
medicine.medical_specialty, Oncology, business.industry, Internal medicine, First line, Phase (matter), Medicine, Hematology, Gastroesophageal Junction Adenocarcinoma, business, Placebo, Gastroenterology
Published
2020
Full Text
View/download PDF

4. 198TiP SPOTLIGHT: Phase III study of zolbetuximab + mFOLFOX6 versus placebo + mFOLFOX6 in first-line Claudin18.2⁺/HER2⁻ advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)

Author

Peter C. Enzinger, Sunnie S. Kim, R. Xu, Daniel Virgil Thomas Catenacci, E. Van Cutsem, Y.-J. Bang, K. Shitara, Manish A. Shah, David H. Ilson, A. Arozullah, Jaffer A. Ajani, Jung Wook Park, Florian Lordick, and S-E. Al-Batran

Subjects
medicine.medical_specialty, Oncology, business.industry, Internal medicine, First line, medicine, Hematology, Gastroesophageal Junction Adenocarcinoma, business, Placebo, Gastroenterology
Published
2020
Full Text
View/download PDF

5. SO-28 A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer

Author

H. Abdul Sater, Jason M. Redman, Ravi A. Madan, Benjamin A. Weinberg, J. Schlom, J.-M. Lee, Fatima Karzai, Margaret E. Gatti-Mays, Lisa M. Cordes, Shahrooz Rabizadeh, Seth M. Steinberg, Patrick Soon-Shiong, Jennifer L. Marte, Renee N. Donahue, S. Gandhy, Yo-Ting Tsai, John L. Marshall, Julius Strauss, Sheri McMahon, Sunnie S. Kim, Marijo Bilusic, and James L. Gulley

Subjects
Oncology, medicine.medical_specialty, Standard of care, Colorectal cancer, business.industry, Hematology, CEA Vaccine, medicine.disease, Avelumab, Internal medicine, medicine, In patient, business, medicine.drug
Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results